MENU
+Compare
AQB
Stock ticker: NASDAQ
AS OF
Feb 21 closing price
Price
$0.72
Change
-$0.01 (-1.37%)
Capitalization
7.77M

AQB AquaBounty Technologies Forecast, Technical & Fundamental Analysis

a biotechnology company focused on improving productivity in commercial aquaculture

AQB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for AQB with price predictions
Feb 21, 2025

AQB in upward trend: price expected to rise as it breaks its lower Bollinger Band on February 21, 2025

AQB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 37 cases where AQB's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 75 cases where AQB's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The 10-day moving average for AQB crossed bullishly above the 50-day moving average on February 14, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 11 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AQB advanced for three days, in of 227 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on February 18, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on AQB as a result. In of 92 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for AQB turned negative on January 29, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at .

AQB moved below its 50-day moving average on February 20, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AQB declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.045) is normal, around the industry mean (15.316). P/E Ratio (0.000) is within average values for comparable stocks, (25.824). AQB's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (18.004). AQB has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.045). P/S Ratio (3.035) is also within normal values, averaging (7.681).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. AQB’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AQB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock worse than average.

View a ticker or compare two or three
AQB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

AQB is expected to report earnings to fall 95.21% to -7 cents per share on March 07

AquaBounty Technologies AQB Stock Earnings Reports
Q4'23
Est.
$-0.08
Q3'23
Beat
by $0.34
Q2'23
Missed
by $0.01
Q1'23
Missed
by $0.01
Q4'22
Est.
$-0.08
The last earnings report on November 07 showed earnings per share of -160 cents, beating the estimate of -194 cents. With 15.27K shares outstanding, the current market capitalization sits at 7.77M.
A.I. Advisor
published General Information

General Information

a biotechnology company focused on improving productivity in commercial aquaculture

Industry AgriculturalCommoditiesMilling

Profile
Fundamentals
Details
Industry
Biotechnology
Address
2 Mill and Main Place
Phone
+1 978 648-6000
Employees
100
Web
https://www.aquabounty.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SHPH0.620.02
+3.70%
Shuttle Pharmaceuticals Holdings Inc
TXT72.34-0.09
-0.12%
Textron
CAPR15.00-0.15
-0.99%
Capricor Therapeutics
HWBK32.96-0.68
-2.02%
Hawthorn Bancshares
FORM35.38-2.01
-5.38%
FormFactor

AQB and Stocks

Correlation & Price change

A.I.dvisor tells us that AQB and TSN have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AQB and TSN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AQB
1D Price
Change %
AQB100%
-0.72%
TSN - AQB
21%
Poorly correlated
+2.27%
ALCO - AQB
20%
Poorly correlated
+0.68%
LMNR - AQB
20%
Poorly correlated
-0.57%
SANW - AQB
19%
Poorly correlated
-3.23%
VFF - AQB
17%
Poorly correlated
+4.55%
More